Respiratory and circulatory changes and arterial levels of halothane were measured in five severe asthmatic patients to determine the effects of intravenous administration of isoprenaline during anaesthesia. Pulmonary compliance and resistance were not significantly altered despite increase in tidal volume. Although respiratory rate remained unchanged, peak flow rate and minute volume increased during infusion. An increase in Pa 02 and in Pa C02 was observed but was not significant. The respiratory stimulation had decreased but had not returned to the control level 10 minutes after the completion of the drug administration.
Occasionally, anaesthetists must provide general anaesthesia for asthmatic patients who present the possibility of developing a bronchospastic attack during anaesthesia and surgery. Isoprenaline, a sympathetic nervous system beta-receptor stimulator, has been utilized as a potent and predictable bronchodilator since its introduction 20 years ago (Gay and Long, 1949) . It has been administered by many routes, including: oral, sublingual, intravenous and inhalation. To assess the effect of isoprenaline when given intravenously, we measured dynamic pulmonary compliance (CL) and resistance (RL), respiratory volumes and arterial blood-gases, in addition to blood pressure and heart rate. These measurements were made simultaneously or within 15-30 seconds of each other in anaesthetized asthmatic patients before, during and after the intravenous infusion of isoprenaline.
METHODS
Five patients with known chronic obstructive airway disease under active treatment for "asthma" were brought to the anaesthesia laboratory prior to elective surgery. Informed consent was obtained. Premedication consisted of pentobarbitone 100 mg and atropine 0.5 mg injected intramuscularly approximately 1 hour before induction of anaesthesia. All patients were using isoprenaline nebulizers and, although three were wheezing, none was in visible difficulty or in a clinically diagnosed asthmatic attack. Pulmonary resistance was slightly elevated in all patients (table II) . With topical analgesia a latex balloon was passed transnasally into the mid-third of the oesophagus and a Cournand needle inserted into the brachial artery. Arterial blood pressure and pulse rate were monitored with the use of a strain gauge and recording oscillograph. A Fleisch pneumotachograph was interposed within the toand-fro carbon dioxide absorption system such that flow rate (V) and tidal volume (VT) could be measured (Gold and Helrich, 1965a) . CL and RL were calculated from a series of 10-15 breaths according to the technique which has been described in detail previously (Gold and Helrich, 1965a, b; Gold, Han and Helrich, 1966) . Bloodgases and arterial halothane levels were measured according to the techniques previously described (Gold, Han and Helrich, 1966) . Data on pulmonary mechanics and blood-gas values were obtained after the conscious patient had breathed 100 per cent oxygen through a non-rebreathing valve, followed by 50 per cent oxygen in nitrogen for an additional 5 minutes. This same 50 per cent oxygen concentration was inhaled during subsequent nitrous oxide-halothane anaesthesia with the use of the to-and-fro carbon dioxide absorption system. After induction of anaesthesia Supported by National Institutes of Health Grant HE-06429.
tracheal intubation was facilitated with the use of small doses of suxamethonium and the patients breathed spontaneously during the remainder of the investigation. Approximately 30 minutes after induction a second group of measurements was obtained and at this time an intravenous infusion of isoprenaline was initiated at a rate of 24 /tg/min. A 5-minute period of isoprenaline administration was followed by a third series of measurements. The fourth group of measurements was obtained during spontaneous breathing 10 minutes after the termination of the infusion of isoprenaline.
RESULTS
Patient characteristics may be seen in table I. The data as obtained in these asthmatic patients are expressed as averages +1 SD for the four groups of measurements on the horizontal axes of four bar graphs (figs. 1-4): (a) awake, control; (b) during anaesthesia and spontaneous breathing prior to the administration of isoprenaline; (c) at the termination of the 5-minute intravenous infusion of isoprenaline; and (d) 10 minutes after termination of this infusion. During these four situations the pulmonary mechanics results are seen in figure 1 , the blood gases in figure 2, the minute volume and peak flow rates in figure  3 and the circulatory phenomena in figure 4 . Detailed results are shown in table II. Before, during and after isoprenaline infusion depth of anaesthesia was relatively similar from patient to patient and from situation to situation. This can be surmised from arterial halothane levels in figure 1. Infusion of isoprenaline influenced pulmonary mechanics and blood-gases little, but increased minute volume, peak flow rates, pulse rates and decreased diastolic blood pressure.
The influence of isoprenaline in pulmonary resistance was surprising in that the expected decrease in these asthmatic patients having a previously elevated resistance was not obtained. A reduction in pulmonary resistance during anaesthesia did occur before the administration of isoprenaline but this was related to intubation and elimination of upper airway resistance (Gold and Helrich, 1965b) . Immediately after the administration of isoprenaline the resistance rose slightly. None of these changes in mechanics is statistically significant. Isoprenaline is an accepted and useful bronchodilator but, depending on the dose administered and the state of the patient, its effects may be unpredictable. In general, when the drug is ineffectual a larger dose is used. The absence of a change in pulmonary mechanics, and especially in resistance observed after isoprenaline infusion in these asthmatic patients, was unexpected. In addition, compliance usually changes in the direction of change in tidal volume (Gold and Helrich, 1965a) . Again, this relationship was not borne out in this study, where a significant increase in tidal volume at the termination of isoprenaline infusion was attended by little or no change in compliance.
In figure 2 the results of Pa 02 , pH and Pa C02 determinations are shown during the conditions stated. During administration of 50 per cent oxygen Pa O2 rose from 150 mm Hg while awake to 175 mm Hg during isoprenaline infusion in the anaesthetized patient and slightly higher afterwards. Respiratory acidosis occurred during anaesthesia but this probably was related to an increase in mechanical deadspace due to channelling of the carbon dioxide absorber. The administration of isoprenaline exerted little influence on both pH and Pa C02 in these patients. Effect of isoprenaline on pulmonary mechanics, blood-gases, flow rate and peak inspiratory flow rate and systolic-diastolic blood pressure and pulse rate in five asthmatic patients awake and anaesthetized. * P<0.05, Student's t test. Figure 3 indicates that inspiratory minute volume decreased during anaesthesia. At the termination of the infusion, minute volume increased but fell 10 minutes later. Peak inspiratory flow rate rose from 18 to 23 l./min during the isoprenaline administration (table II) . Mean respiratory rate stayed at the same level of about 25 b.p.m. Figure 4 shows the changes in blood pressure and heart rate. Systolic pressure did not change greatly but there was a significant reduction in diastolic pressure (P<0.05) during the administration of isoprenaline. Heart rate increased from approximately 90 to 130 beats/min during infusion (P<0.05). After infusion, heart rate decreased but did not quite reach control levels.
DISCUSSION
There is a possibility that blood level of isoprenaline sufficient to cause bronchodilatation was not obtained at the rate of infusion employed in this study. However, we were reluctant to use larger doses in the presence of halothane anaesthesia for fear of cardiac arrhythmias (Takaori and Loehning, 1965) . In fact, such arrhythmias did occur in two patients but subsided spontaneously. Blood levels of isoprenaline were high enough to increase heart rate and decrease diastolic pressure significantly. If this were so why were these levels not sufficient to create a measurable decrease in pulmonary resistance? There is some evidence that administration of isoprenaline by nebulization is more efficient in producing bronchodilatation than it is by other routes (Dautrebande and Heymans, 1961; Feinmann and Newell, 1963) . It has been suggested that asthmatic patients exhibit partial blockade of smooth muscle beta-receptors to adrenergic stimulation (Cookson and Reed, 1963) . This may partially explain its relative impotency when used intravenously. On the other hand, it has been used successfully by the intravenous route to treat bronchospasm occurring during anaesthesia (Cohen, Van Bergen and Knight, 1949) . The influence of halothane must also be considered since evidence exists to indicate that it is a beta-receptor stimulator (Klide and Aviado, 1967) . However, the degree of such stimulation remains unqualified in humans, particularly asthmatics.
It is also possible that these patients with severe asthma, though not in a clinical attack, had irreversible disease of such a degree that no further bronchodilatation could be expected by pharmacological means. The average pulmonary resistance of 8.6 cm H 2 O/l./sec after tracheal intubation but before isoprenaline represents a substantial decrease from the mask, awake, value of 11.1 cm H 2 O/l./sec. In all probability this is due to the elimination of upper airway resistance with the insertion of the endotracheal tube (Gold and Helrich, 1965b) . These resistance values approach those defined in our laboratory during the last five years as normal (Gold and Helrich, 1965a, b; Gold, Han and Helrich, 1966) .
Another unexpected finding was the relationship between isoprenaline infusion and respiratory stimulation as defined by peak flow, minute volume and arterial Pco 2 . In all probability this is related to similar findings with epinephrine administration. This has been rather crudely attributed to the "flight or fight" phenomenon which animals exhibit when placed in a stress situation. During anaesthesia, however, the neurophysiological mechanism of such respiratory stimulation remains unexplained. The respiratory stimulant effect of isoprenaline has been mentioned (Flecker, 1962; Williams, White and Behnke, 1963 
